Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 27.02.2024
Cherry SE
Cherry SE publishes forecast for the financial year and first quarter of 2024; quarterly reporting better aligned with capital market requirements
Munich, February 27th, 2024 – Cherry SE [ISIN: DE000A3CRRN9] today published its revenue and earnings forecast for the current financial year and the first quarter.
For 2024, the Management Board conti [ … ]
Tue, 27.02.2024
Linde plc
Linde Board Elects Paula Rosput Reynolds as New Director
Woking, UK, February 27, 2024 – Linde plc (Nasdaq: LIN) announced today that its Board of Directors has elected Paula Rosput Reynolds as a new director of Linde plc, effective February 27, 2024. Rosput Reynolds will serve on the Audit and Sustainability committees.
Rosput Reynolds is a seas [ … ]
Tue, 27.02.2024
ProCredit Holding AG
Supervisory Board decides to expand the Management Board of ProCredit Holding AG from 1 April this year
Frankfurt am Main, 27 February 2024 – The Supervisory Board of ProCredit Holding AG has appointed Mr Christoph Beeck and Mr George Chatzis as members of the Management Board for three years with effect from 1 April 2024.
Christoph Beeck [ … ]
Tue, 27.02.2024
Viscom AG
Viscom AG: Executive Board resolves one-off dividend reduction to conserve liquidity
Hanover, 27 February 2024 – The Executive Board of Viscom AG (ISIN DE0007846867), today decided at its extraordinary meeting, following the conclusion of a company agreement on short-time work, to propose to the Annual General Meeting a significantly reduced divid [ … ]
Tue, 27.02.2024
Cardiol Therapeutics Inc
First Berlin Equity Research has published a research update on Cardiol
Therapeutics Inc. (ISIN: CA14161Y2006). Analyst Christian Orquera
reiterated his BUY rating and maintained his USD 3.60 price target.
Abstract:
Cardiol Therapeutics (Cardiol) announced that the FDA has granted Orphan
Drug Designation (ODD) in the US for its lead drug candid [ … ]
Tue, 27.02.2024
Mainz BioMed N.V.
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
BERKELEY, US – MAINZ, Germany – February 27th 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, is proud to annou [ … ]
Tue, 27.02.2024
Agri Resources Group S.A.
Disclosure of inside information pursuant to Art. 17 of Regulation (EU) No 596/2014
AGRI RESOURCES GROUP calls Noteholders’ meeting for vote in favor of certain amendments to the terms and conditions of the 2021/2026 Notes to facilitate strategic repositioning
Luxembourg, 27 February 2024 - The Management of AGRI RESOURCES GROUP S.A., Luxe [ … ]
Tue, 27.02.2024
PANTAFLIX AG
PANTAFLIX AG: Anti-war film THE TIGER to be released on Amazon Prime in 2025
Munich, 27 February 2024. PANTALEON Films, a wholly owned film production subsidiary of PANTAFLIX AG (GSIN: A12UPJ; ISIN: DE000A12UPJ7), is in post-production on the anti-war film THE TIGER (working title) for Amazon Prime Video. The film is expected to be released exclusi [ … ]
Tue, 27.02.2024
RATIONAL AG
The Beginning of a New Era – RATIONAL introduces a new product category: the RATIONAL iHexagon delivers the highest food quality in the shortest possible time.
RATIONAL is starting the new year with a World Premiere: With the new iHexagon, the world market leader has succeeded in coordinating steam, hot air and microwave technology so intelligent [ … ]
Tue, 27.02.2024
EcoGraf Limited
ASX Release / 27 February 2024
German Research Institute Confirms Recycled Graphite Performance
Lithium-ion cell confirms excellent cycling stability after 1000 cycles
EcoGraf Limited (EcoGraf or the Company) (ASX: EGR; FSE: FMK; OTCQB: ECGFF) is pleased to provide the positive findings from a research program completed by the Helmholtz Institut [ … ]